Advisor Shares Investments LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Advisor Shares Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$1.01 - $1.82 $484,247 - $872,604	-479,453 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$1.39 - $2.21 $16,225 - $25,797	-11,673 Reduced 2.38%	479,453 $877,000
Q1 2021 May 11, 2021	BUY	$1.27 - $3.42 $278,451 - $749,845	219,253 Added 80.65%	491,126 $968,000
Q4 2020 Jan 25, 2021	SELL	$0.94 - $1.89 $7,330 - $14,738	-7,798 Reduced 2.79%	271,873 $340,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $9.38 $134,785 - $842,858	89,857 Added 47.34%	279,671 $504,000

Q2 2020 Jul 14, 2020	SELL	$4.79 - $8.39 $603,899 - $1.06 Million	-126,075 Reduced 39.91%	189,814 $1.59 Million
Q1 2020 May 13, 2020	SELL	$3.44 - $7.21 $223,121 - $467,647	-64,861 Reduced 17.04%	315,889 $1.66 Million
Q4 2019 Jan 22, 2020	BUY	$4.29 - $5.64 $1.63 Million - $2.15 Million	380,750 New	380,750 $2.08 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $6.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Shares Investments LLC with notifications on news.